Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy W Pang

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Hematology|April 13, 2012
Anemia in the elderlyWendy W Pang, Stanley L Schrier
Seminars in Hematology|January 17, 2017
Age-associated changes in human hematopoietic stem cellsWendy W Pang, Stanley L Schrier, Irving L Weissman
The Journal of Allergy and Clinical Immunology|March 17, 2026
Mast cell depletion and repopulation dynamics define briquilimab efficacy in a mouse model of allergic asthmaMang Yu, Sara Ratia, Sambidhan Kattel, et al.
Transplantation and Cellular Therapy|July 7, 2024
Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid LeukemiaDawoon Jung, Janel R Long-Boyle, Wendy W Pang, et al.
Blood Advances|August 27, 2021
5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent miceAndriyana K Bankova, Wendy W Pang, Brenda J Velasco, et al.
Microbiology Spectrum|October 21, 2016
Myeloid Cell Origins, Differentiation, and Clinical ImplicationsKipp Weiskopf, Peter J Schnorr, Wendy W Pang, et al.
Blood|February 13, 2019
Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted miceWendy W Pang, Agnieszka Czechowicz, Aaron C Logan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2009
Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched miceThai M Cao, Laura C Lazzeroni, Schickwann Tsai, et al.
Cell|July 28, 2009
CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cellsRavindra Majeti, Mark P Chao, Ash A Alizadeh, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with ageWendy W Pang, Elizabeth A Price, Debashis Sahoo, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Hematology|April 13, 2012
Anemia in the elderlyWendy W Pang, Stanley L Schrier
Seminars in Hematology|January 17, 2017
Age-associated changes in human hematopoietic stem cellsWendy W Pang, Stanley L Schrier, Irving L Weissman
The Journal of Allergy and Clinical Immunology|March 17, 2026
Mast cell depletion and repopulation dynamics define briquilimab efficacy in a mouse model of allergic asthmaMang Yu, Sara Ratia, Sambidhan Kattel, et al.
Transplantation and Cellular Therapy|July 7, 2024
Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid LeukemiaDawoon Jung, Janel R Long-Boyle, Wendy W Pang, et al.
Blood Advances|August 27, 2021
5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent miceAndriyana K Bankova, Wendy W Pang, Brenda J Velasco, et al.
Microbiology Spectrum|October 21, 2016
Myeloid Cell Origins, Differentiation, and Clinical ImplicationsKipp Weiskopf, Peter J Schnorr, Wendy W Pang, et al.
Blood|February 13, 2019
Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted miceWendy W Pang, Agnieszka Czechowicz, Aaron C Logan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2009
Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched miceThai M Cao, Laura C Lazzeroni, Schickwann Tsai, et al.
Cell|July 28, 2009
CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cellsRavindra Majeti, Mark P Chao, Ash A Alizadeh, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with ageWendy W Pang, Elizabeth A Price, Debashis Sahoo, et al.
Pageof 3